Product Description
Terconazole is used to treat fungal and yeast infections of the vagina. (Sourced from: https://medlineplus.gov/druginfo/meds/a688022.html)
Mechanisms of Action: Cell Wall Inhibitor,Ergosterol Synthesis Inhibitor,CYP51 Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Vaginal
FDA Designation: None *
Approval Status: Approved
Approved Countries: Bangladesh | Brazil | Canada | Colombia | Egypt | India | Ireland | Italy | Peru | Portugal | Taiwan | United States
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|